Hospital Medicine

Investigators find that opening all blockages with stents is more beneficial after a heart attack than targeting just the clogged artery causing the event.

Results of the PARAGON HF study, which were presented at ESC Congress 2019, reveal no significant benefit of sacubitril-valsartan compared to valsartan for heart failure with preserved ejection fraction in more than 4,500 patients.

In a new clinical trial, investigators found a FAAH inhibitor improves the recall of fear extinction memories while reducing the impact of stress in PTSD patients.

The FDA warns of liver failure in rare cases from taking Mavyret, Zepatier, and Vosevi to treat hepatitis C.

In a multi-country study, investigators find that the US could reduce the number of deaths for patients waiting for kidney transplants if they accept older kidneys.

A new FDA approval allows istradefylline to be taken as an add-on with other medication to reduce the time medication does not work in Parkinson disease patients.

Despite a common belief that medications treating mental illnesses are connected to weight gain, new data shows an individual in a weight management program will lose weight whether or not they are taking antidepressants or antipsychotics.

A Mayo Clinic study examining artificial intelligence to analyze ECG data found readings can be used as a predictor of overall physiological health.

A primary investigator-led discussion will tap into how invasive procedures have become more embraced in US cardiology.

A 600-city analysis of particulate matter found daily exposure is linked to worsened mortality rates, particularly in areas with higher mean temperatures.

New data suggests that type 2 diabetes linked to PTSD are less likely to occur among patients with clinically meaningful PTSD symptom reduction through treatment or spontaneous improvement.

In a comprehensive new study, investigators discover unique patterns in the brains of both family members and patients with psychotic disorders, including bipolar disorder and schizophrenia.

In a new study, investigators examine the efficacy and tolerability of antipsychotic medications for patients in remission for psychotic depression.

In a new population-based study, investigators discover sex differences in burdensome interventions and antibiotic therapy for nursing home residents with advanced dementia in Canada.

FDA announced the approval of lefamulin, which was based on the results of the LEAP 1 and LEAP 2 trials.